|
|
| | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide Basic information |
| Product Name: | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide | | Synonyms: | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide;7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-5,5-dioxo-4H-thieno[3,2-c]thiochromene-2-carboxamide | | CAS: | 2595314-46-6 | | MF: | C34H27NO5S2 | | MW: | 593.71 | | EINECS: | | | Product Categories: | | | Mol File: | 2595314-46-6.mol | ![4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide Structure](CAS/20210305/GIF/2595314-46-6.gif) |
| | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide Chemical Properties |
| Boiling point | 907.9±65.0 °C(Predicted) | | density | 1.328±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (168.43 mM; Need ultrasonic) | | pka | 12.62±0.20(Predicted) | | form | Solid | | color | Off-white to light yellow |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide Usage And Synthesis |
| Uses | WEHI-9625 is a tricyclic sulfone, first-in-class inhibitor of apoptosis with an EC50 of 69 nM. WEHI-9625 binds to VDAC2 and promotes its ability to inhibit apoptosis driven by mouse BAK. WEHI-9625 is completely inactive against both human BAK and the closely related apoptosis effector BAX[1]. | | Biological Activity | WEHI-9625 is a tricyclic sulfone, first-in-class inhibitor of apoptosis with an EC50 of 69 nM. WEHI-9625 binds to VDAC2 and promotes its ability to inhibit apoptosis driven by mouse BAK. WEHI-9625 is completely inactive against both human BAK and the closely related apoptosis effector BAX[1].
WEHI-9625 (0-10 μM; Mcl1-/-Bax-/- MEFs cells) treatment could prevent cell death mediated by BAK and potently inhibits BIM BH3-induced loss of mitochondrial membrane potential in Bax-/-, but not Bak-/-, cells[1].
WEHI-9625 demonstrates that blocking apoptosis at an early stage was both advantageous and pharmacologically tractable[1]. | | in vivo | WEHI-9625 demonstrates that blocking apoptosis at an early stage was both advantageous and pharmacologically tractable[1]. | | IC 50 | Bak; Bax | | References | [1]. van Delft MF, et al. A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis. Nat Chem Biol. 2019 Oct 7. |
| | 4H-Thieno[3,2-c][1]benzothiopyran-2-carboxamide, 7-[2-(4-methoxybenzoyl)phenyl]-N-[(4-methylphenyl)methyl]-, 5,5-dioxide Preparation Products And Raw materials |
|